Showing results (101-110 of 176) with videos related to
Sort By:
Pageof 18
Plos One|March 3, 2017
Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virusEisuke Miyaki, Nobuhiko Hiraga, Michio Imamura, et al.Journal of Medical Virology|April 20, 2011
Common genetic polymorphism of ITPA gene affects ribavirin-induced anemia and effect of peg-interferon plus ribavirin therapyTakahiro Azakami, C Nelson Hayes, Hitomi Sezaki, et al.Journal of Experimental & Clinical Cancer Research : CR|June 27, 2021
Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinibYasutoshi Fujii, Atsushi Ono, C Nelson Hayes, et al.Journal of Viral Hepatitis|December 28, 2022
A novel cDNA-uPA/SCID/Rag2-/- /Jak3-/- mouse model for hepatitis virus infection and reconstruction of human immune systemTakuro Uchida, Yuji Teraoka, Michio Imamura, et al.Journal of Gastroenterology|January 20, 2011
Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis CKazuaki Chayama, C Nelson Hayes, Kentaro Yoshioka, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 3, 2010
Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis CKazuaki Chayama, C Nelson Hayes, Kentaro Yoshioka, et al.Journal of Hepatology|December 15, 2010
ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivoHiromi Abe, Michio Imamura, Nobuhiko Hiraga, et al.Journal of Medical Virology|October 5, 2019
Ribavirin induces hepatitis C virus genome mutations in chronic hepatitis patients who failed to respond to prior daclatasvir plus asunaprevir therapyYuhei Saito, Michio Imamura, Takuro Uchida, et al.Antimicrobial Agents and Chemotherapy|April 5, 2017
Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B VirusMasataka Tsuge, Takuro Uchida, Nobuhiko Hiraga, et al.The Journal of General Virology|June 20, 2018
Limitations of daclatasvir/asunaprevir plus beclabuvir treatment in cases of NS5A inhibitor treatment failureYuji Teraoka, Takuro Uchida, Michio Imamura, et al.Pageof 18